Endometrial stromal sarcomas and related high-grade sarcomas

Immunohistochemical and molecular genetic study of 31 cases

Shuichi Kurihara, Yoshinao Oda, Yoshihiro Ohishi, Atsuko Iwasa, Tomonari Takahira, Kaneki Eisuke, Hiroaki Kobayashi, Norio Wake, Masazumi Tsuneyoshi

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

Classification and terminology of non-low-grade endometrial sarcomas, which show significant nuclear atypia, have been controversial. Currently, these tumors seem to be classified all together into "undifferentiated endometrial sarcoma (UES)." However, it remains unclear whether these non-low-grade sarcomas are universally "undifferentiated." We divided these sarcomas morphologically into undifferentiated endometrial sarcoma with nuclear uniformity (UES-U) and undifferentiated endometrial sarcoma with nuclear pleomorphism (UES-P), and compared their molecular genetic and immunohistochemical profiles. Eighteen low-grade endometrial stromal sarcomas (ESS-LG), 7 UES-U, and 6 UES-P were examined. All the patients with ESS-LG were still alive, either with or without disease, whereas 4 of the 5 patients with advanced stage UES-U and all 3 of the patients with advanced stage UES-P had died of the disease. JAZF1-JJAZ1 fusion transcript was detected in 6 (50%) out of 12 ESS-LG and in 1 (33%) of 3 UES-U, whereas it was not detected in any of the cases of UES-P. ESS-LG and UES-U frequently showed positive immunoreaction for estrogen receptor (ESS-LG: 94%, UES-U: 57%) and progesterone receptor (ESS-LG: 94%, UES-U: 57%), whereas all the UES-P were negative for these receptors. Nuclear β-catenin expression was more frequently recognized in ESS-LG (47%) and UES-U (85%), compared with UES-P (33%). Moreover, nuclear accumulation of p53 and TP53 gene missense mutations were limited to 3 UES-P cases. Our data suggest that UES-U shares some molecular genetic and immunohistochemical characteristics with ESS-LG, but UES-P considerably differs from ESS-LG.

Original languageEnglish
Pages (from-to)1228-1238
Number of pages11
JournalAmerican Journal of Surgical Pathology
Volume32
Issue number8
DOIs
Publication statusPublished - Aug 1 2008

Fingerprint

Endometrial Stromal Sarcoma
Sarcoma
Molecular Biology
p53 Genes
Endometrial Stromal Tumors

All Science Journal Classification (ASJC) codes

  • Anatomy
  • Surgery
  • Pathology and Forensic Medicine

Cite this

Endometrial stromal sarcomas and related high-grade sarcomas : Immunohistochemical and molecular genetic study of 31 cases. / Kurihara, Shuichi; Oda, Yoshinao; Ohishi, Yoshihiro; Iwasa, Atsuko; Takahira, Tomonari; Eisuke, Kaneki; Kobayashi, Hiroaki; Wake, Norio; Tsuneyoshi, Masazumi.

In: American Journal of Surgical Pathology, Vol. 32, No. 8, 01.08.2008, p. 1228-1238.

Research output: Contribution to journalArticle

Kurihara, Shuichi ; Oda, Yoshinao ; Ohishi, Yoshihiro ; Iwasa, Atsuko ; Takahira, Tomonari ; Eisuke, Kaneki ; Kobayashi, Hiroaki ; Wake, Norio ; Tsuneyoshi, Masazumi. / Endometrial stromal sarcomas and related high-grade sarcomas : Immunohistochemical and molecular genetic study of 31 cases. In: American Journal of Surgical Pathology. 2008 ; Vol. 32, No. 8. pp. 1228-1238.
@article{bad62949c4654e05ad1236fb6e3c3041,
title = "Endometrial stromal sarcomas and related high-grade sarcomas: Immunohistochemical and molecular genetic study of 31 cases",
abstract = "Classification and terminology of non-low-grade endometrial sarcomas, which show significant nuclear atypia, have been controversial. Currently, these tumors seem to be classified all together into {"}undifferentiated endometrial sarcoma (UES).{"} However, it remains unclear whether these non-low-grade sarcomas are universally {"}undifferentiated.{"} We divided these sarcomas morphologically into undifferentiated endometrial sarcoma with nuclear uniformity (UES-U) and undifferentiated endometrial sarcoma with nuclear pleomorphism (UES-P), and compared their molecular genetic and immunohistochemical profiles. Eighteen low-grade endometrial stromal sarcomas (ESS-LG), 7 UES-U, and 6 UES-P were examined. All the patients with ESS-LG were still alive, either with or without disease, whereas 4 of the 5 patients with advanced stage UES-U and all 3 of the patients with advanced stage UES-P had died of the disease. JAZF1-JJAZ1 fusion transcript was detected in 6 (50{\%}) out of 12 ESS-LG and in 1 (33{\%}) of 3 UES-U, whereas it was not detected in any of the cases of UES-P. ESS-LG and UES-U frequently showed positive immunoreaction for estrogen receptor (ESS-LG: 94{\%}, UES-U: 57{\%}) and progesterone receptor (ESS-LG: 94{\%}, UES-U: 57{\%}), whereas all the UES-P were negative for these receptors. Nuclear β-catenin expression was more frequently recognized in ESS-LG (47{\%}) and UES-U (85{\%}), compared with UES-P (33{\%}). Moreover, nuclear accumulation of p53 and TP53 gene missense mutations were limited to 3 UES-P cases. Our data suggest that UES-U shares some molecular genetic and immunohistochemical characteristics with ESS-LG, but UES-P considerably differs from ESS-LG.",
author = "Shuichi Kurihara and Yoshinao Oda and Yoshihiro Ohishi and Atsuko Iwasa and Tomonari Takahira and Kaneki Eisuke and Hiroaki Kobayashi and Norio Wake and Masazumi Tsuneyoshi",
year = "2008",
month = "8",
day = "1",
doi = "10.1097/PAS.0b013e31816a3b42",
language = "English",
volume = "32",
pages = "1228--1238",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Endometrial stromal sarcomas and related high-grade sarcomas

T2 - Immunohistochemical and molecular genetic study of 31 cases

AU - Kurihara, Shuichi

AU - Oda, Yoshinao

AU - Ohishi, Yoshihiro

AU - Iwasa, Atsuko

AU - Takahira, Tomonari

AU - Eisuke, Kaneki

AU - Kobayashi, Hiroaki

AU - Wake, Norio

AU - Tsuneyoshi, Masazumi

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Classification and terminology of non-low-grade endometrial sarcomas, which show significant nuclear atypia, have been controversial. Currently, these tumors seem to be classified all together into "undifferentiated endometrial sarcoma (UES)." However, it remains unclear whether these non-low-grade sarcomas are universally "undifferentiated." We divided these sarcomas morphologically into undifferentiated endometrial sarcoma with nuclear uniformity (UES-U) and undifferentiated endometrial sarcoma with nuclear pleomorphism (UES-P), and compared their molecular genetic and immunohistochemical profiles. Eighteen low-grade endometrial stromal sarcomas (ESS-LG), 7 UES-U, and 6 UES-P were examined. All the patients with ESS-LG were still alive, either with or without disease, whereas 4 of the 5 patients with advanced stage UES-U and all 3 of the patients with advanced stage UES-P had died of the disease. JAZF1-JJAZ1 fusion transcript was detected in 6 (50%) out of 12 ESS-LG and in 1 (33%) of 3 UES-U, whereas it was not detected in any of the cases of UES-P. ESS-LG and UES-U frequently showed positive immunoreaction for estrogen receptor (ESS-LG: 94%, UES-U: 57%) and progesterone receptor (ESS-LG: 94%, UES-U: 57%), whereas all the UES-P were negative for these receptors. Nuclear β-catenin expression was more frequently recognized in ESS-LG (47%) and UES-U (85%), compared with UES-P (33%). Moreover, nuclear accumulation of p53 and TP53 gene missense mutations were limited to 3 UES-P cases. Our data suggest that UES-U shares some molecular genetic and immunohistochemical characteristics with ESS-LG, but UES-P considerably differs from ESS-LG.

AB - Classification and terminology of non-low-grade endometrial sarcomas, which show significant nuclear atypia, have been controversial. Currently, these tumors seem to be classified all together into "undifferentiated endometrial sarcoma (UES)." However, it remains unclear whether these non-low-grade sarcomas are universally "undifferentiated." We divided these sarcomas morphologically into undifferentiated endometrial sarcoma with nuclear uniformity (UES-U) and undifferentiated endometrial sarcoma with nuclear pleomorphism (UES-P), and compared their molecular genetic and immunohistochemical profiles. Eighteen low-grade endometrial stromal sarcomas (ESS-LG), 7 UES-U, and 6 UES-P were examined. All the patients with ESS-LG were still alive, either with or without disease, whereas 4 of the 5 patients with advanced stage UES-U and all 3 of the patients with advanced stage UES-P had died of the disease. JAZF1-JJAZ1 fusion transcript was detected in 6 (50%) out of 12 ESS-LG and in 1 (33%) of 3 UES-U, whereas it was not detected in any of the cases of UES-P. ESS-LG and UES-U frequently showed positive immunoreaction for estrogen receptor (ESS-LG: 94%, UES-U: 57%) and progesterone receptor (ESS-LG: 94%, UES-U: 57%), whereas all the UES-P were negative for these receptors. Nuclear β-catenin expression was more frequently recognized in ESS-LG (47%) and UES-U (85%), compared with UES-P (33%). Moreover, nuclear accumulation of p53 and TP53 gene missense mutations were limited to 3 UES-P cases. Our data suggest that UES-U shares some molecular genetic and immunohistochemical characteristics with ESS-LG, but UES-P considerably differs from ESS-LG.

UR - http://www.scopus.com/inward/record.url?scp=49249084749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49249084749&partnerID=8YFLogxK

U2 - 10.1097/PAS.0b013e31816a3b42

DO - 10.1097/PAS.0b013e31816a3b42

M3 - Article

VL - 32

SP - 1228

EP - 1238

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 8

ER -